FDA panel backs Pfizer Covid-19 vaccine for 5- to 11-year-olds

Data from drugmaker and US regulator suggest advantages of Covid-19 jab would far outweigh risks
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news